Piramal All Set To Buy Coldstream From University Of Kentucky
Advertisement
Advertisement
Healthcare giant “Of this, $5.65 million would be towards the Coldstream facility on the Research Park Campus of the University, while the rest would be towards purchase of the company’s shares. This potential transaction is subject to corporate approvals and is expected to be completed by the end of this week,” said the company in a letter to the National Stock Exchange (NSE).
Coldstream is focused developing and manufacturing sterile injectable products and is owned by University of Kentucky Research Foundation. The company’s headquarter is in Lexington in Kentucky in the US.
“This acquisition allows PEL to move further into the injectable market segment and has strong synergy with its existing Pharma Solutions business,” added the company.
The deal is not subject to any regulatory approvals.
Advertisement
Image: Official website of Piramal
Advertisement
- 6 reasons why you should visit Ladakh this summer
- TVS iQube gets a new variant priced under ₹1 lakh, ST variant gets a bigger battery
- As English players begin their premature IPL exodus, Gavaskar calls for action against England Cricket Board
- Top 10 destinations for river rafting in India in 2024
- Should you enrol your child in an online university like IGNOU?
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market